Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jan;21(1):96-104.
doi: 10.1111/j.1750-3639.2010.00455.x.

Molecular diagnostics in embryonal brain tumors

Affiliations
Review

Molecular diagnostics in embryonal brain tumors

Charles G Eberhart. Brain Pathol. 2011 Jan.

Abstract

Embryonal brain tumors are a heterogeneous group of neoplasms united by the presence of poorly differentiated stem-like cells. Molecular details are increasingly being used to separate them into biologically and clinically meaningful groups. For medulloblastoma, integrated mRNA expression profiling and DNA analysis by a number of research groups defines 4-6 distinctive molecular variants. A subset with prominent Wnt activity is associated with good clinical outcomes and classic histology. Medulloblastomas showing a Hedgehog gene expression signature are frequently of the desmoplastic/nodular subtype. Interestingly, Hedgehog activity is found in tumors arising either in infants or older teenagers and adults. The association of clinically aggressive medulloblastoma with MYC expression, large cell/anaplastic change and high levels of photoreceptor differentiation transcripts has also been noted in several studies. Immunohistochemical analysis of just one or two genes per molecular medulloblastoma variant may be sufficient for accurate classification, and this would be of great practical utility if validated. Advances have also been made in the classification of central nervous system (CNS) Primitive Neuroectodermal Tumors (PNET), as several groups have identified an amplicon at chromosome 19q13.41-42, which appears to define a unique PNET subtype associated with prominent true rosettes, young age and very poor outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Embryonal brain tumor histopathology. A. “Classic” medulloblastoma lack distinctive features and are comprised of sheets of poorly differentiated cells. B. Desmoplastic/nodular medulloblastoma contain scattered pale islands of differentiated cells (asterisk) surrounded by more pleomorphic internodular zones. C. Medulloblastoma with extensive nodularity contain back to back nodules which can extend into elongated streams of neuropil surrounding rows of small round tumor cells. D. Large cell medulloblastoma are characterized by plump, round, discohesive tumor cells with prominent nucleoli (asterisk), while in anaplastic medulloblastoma nuclei are angular and molded (right side). As seen in this panel, both patterns can co‐exist in a single tumor. E. Atypical teratoid/rhabdoid tumors often have a “jumbled” appearance, and rhabdoid cells can be hard to find. F. Central nervous ystem (CNS) primitive neuroectodermal tumors (PNET) can have a variety of appearances; this supratentorial case contains anaplastic foci (asterisks). G. Embryonal tumors with abundant neuropil and true rosettes (ETANTR) feature multilayered rosettes often arising from paucicellular regions rich in tumor neuropil. H. Other regions of ETANTR can lack the distinctive rosettes and neuropil. (Original magnification 400 × for all images).
Figure 2
Figure 2
Molecular classification of medulloblastoma.

Similar articles

Cited by

References

    1. Adamson DC, Shi Q, Wortham M, Northcott PA, Di C, Duncan CG et al (2010) OTX2 is critical for the maintenance and progression of Shh‐independent medulloblastomas. Cancer Res 70:181–191. - PMC - PubMed
    1. Aldosari N, Bigner SH, Burger PC, Becker L, Kepner JL, Friedman HS, McLendon RE (2002) MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. Arch Pathol Lab Med 126:540–544. - PubMed
    1. Badiali M, Pession A, Basso G, Andreini L, Rigobello L, Galassi E, Giangaspero F (1991) N‐myc and c‐myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c‐myc amplification. Tumori 77:118–121. - PubMed
    1. Baeza N, Masuoka J, Kleihues P, Ohgaki H (2003) AXIN1 mutations but not deletions in cerebellar medulloblastomas. Oncogene 22:632–636. - PubMed
    1. Batra SK, McLendon RE, Koo JS, Castelino‐Prabhu S, Fuchs HE, Krischer JP et al (1995) Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neurooncol 24:39–45. - PubMed

Publication types

MeSH terms